ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Takeda chief's gamble of a lifetime shakes drugmaker to the core

Christophe Weber in the hot seat as stakeholders weigh $62bn bet on Shire

TOKYO -- The shroud of secrecy was thick, but the Takeda Pharmaceutical director saw and heard enough to make him shudder.

The director was attending a board meeting at the drugmaker's Tokyo headquarters in February. On the table was a document detailing another, anonymous drug company. Takeda President and CEO Christophe Weber said he was looking at acquiring a peer roughly the same size as Takeda. 

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more